Collin J Van Ryn

20162020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2020

MYCN amplification and ATRX mutations are incompatible in neuroblastoma

Zeineldin, M., Federico, S., Chen, X., Fan, Y., Xu, B., Stewart, E., Zhou, X., Jeon, J., Griffiths, L., Nguyen, R., Norrie, J., Easton, J., Mulder, H., Yergeau, D., Liu, Y., Wu, J., Van Ryn, C., Naranjo, A., Hogarty, M. D., Kamiński, M. M. & 17 others, Valentine, M., Pruett-Miller, S. M., Pappo, A., Zhang, J., Clay, M. R., Bahrami, A., Vogel, P., Lee, S., Shelat, A., Sarthy, J. F., Meers, M. P., George, R. E., Mardis, E. R., Wilson, R. K., Henikoff, S., Downing, J. R. & Dyer, M. A., Dec 1 2020, In : Nature communications. 11, 1, 913.

Research output: Contribution to journalArticle

Open Access
5 Scopus citations
2019

Antitumor Activity and Tolerability of hu14.18-IL2 with GMCSF and Isotretinoin in Recurrent or Refractory Neuroblastoma: A Children's Oncology Group phase II study

Shusterman, S., Naranjo, A., van Ryn, C., Hank, J. A., Parisi, M. T., Shulkin, B. L., Servaes, S., London, W. B., Shimada, H., Gan, J., Gillies, S. D., Maris, J. M., Park, J. R. & Sondel, P. M., Oct 15 2019, In : Clinical Cancer Research. 25, 20, p. 6044-6051 8 p.

Research output: Contribution to journalArticle

1 Scopus citations

Prevalence and clinical correlations of somatostatin receptor-2 (SSTR2) expression in neuroblastoma

Alexander, N., Marrano, P., Thorner, P., Naranjo, A., Van Ryn, C., Martinez, D., Batra, V., Zhang, L., Irwin, M. S. & Baruchel, S., Apr 1 2019, In : Journal of pediatric hematology/oncology. 41, 3, p. 222-227 6 p.

Research output: Contribution to journalArticle

1 Scopus citations

Role of the extent of prophylactic regional lymph node radiotherapy on survival in high-risk neuroblastoma: A report from the COG A3973 study

Braunstein, S. E., London, W. B., Kreissman, S. G., Villablanca, J. G., Davidoff, A. M., DeSantes, K., Castleberry, R. P., Murray, K., Diller, L., Matthay, K., Cohn, S. L., Shulkin, B., von Allmen, D., Parisi, M. T., Van Ryn, C., Park, J. R., La Quaglia, M. P. & Haas-Kogan, D. A., Jul 2019, In : Pediatric Blood and Cancer. 66, 7, e27736.

Research output: Contribution to journalArticle

1 Scopus citations

Scalable, semi-automated fluorescence reduction neutralization assay for qualitative assessment of Ebola virus-neutralizing antibodies in human clinical samples

Postnikova, E. N., Pettitt, J., Van Ryn, C. J., Holbrook, M. R., Bollinger, L., Yú, S., Caì, Y., Liang, J., Sneller, M. C., Jahrling, P. B., Hensley, L. E., Kuhn, J. H., Fallah, M. P., Bennett, R. S. & Reilly, C., Aug 1 2019, In : PloS one. 14, 8, e0221407.

Research output: Contribution to journalArticle

Open Access
2 Scopus citations
2018

MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: A report from the children's oncology group

Niemas-Teshiba, R., Matsuno, R., Wang, L. L., Tang, X. X., Chiu, B., Zeki, J., Coburn, J., Ornell, K., Naranjo, A., Ryn, C. V., London, W. B., Hogarty, M. D., Gastier-Foster, J. M., Look, A. T., Park, J. R., Maris, J. M., Cohn, S. L., Seeger, R. C., Asgharzadeh, S., Ikegaki, N. & 1 others, Shimada, H., 2018, In : Oncotarget. 9, 5, p. 6416-6432 17 p.

Research output: Contribution to journalArticle

Open Access
12 Scopus citations
2017

Association of MYCN copy number with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group

Campbell, K., Gastier-Foster, J. M., Mann, M., Naranjo, A. H., Van Ryn, C., Bagatell, R., Matthay, K. K., London, W. B., Irwin, M. S., Shimada, H., Granger, M. M., Hogarty, M. D., Park, J. R. & DuBois, S. G., Nov 1 2017, In : Cancer. 123, 21, p. 4224-4235 12 p.

Research output: Contribution to journalArticle

Open Access
37 Scopus citations

Historical time to disease progression and progression-free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early-phase trials

London, W. B., Bagatell, R., Weigel, B. J., Fox, E., Guo, D., Van Ryn, C., Naranjo, A. & Park, J. R., Dec 15 2017, In : Cancer. 123, 24, p. 4914-4923 10 p.

Research output: Contribution to journalArticle

Open Access
30 Scopus citations

Impact of extent of resection on local control and survival in patients from the COG A3973 study with high-risk neuroblastoma

Von Allmen, D., Davidoff, A. M., London, W. B., Van Ryn, C., Haas-Kogan, D. A., Kreissman, S. G., Khanna, G., Rosen, N., Park, J. R. & La Quaglia, M. P., Jan 10 2017, In : Journal of Clinical Oncology. 35, 2, p. 208-216 9 p.

Research output: Contribution to journalArticle

Open Access
35 Scopus citations

Irinotecan–temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial

Mody, R., Naranjo, A., Van Ryn, C., Yu, A. L., London, W. B., Shulkin, B. L., Parisi, M. T., Servaes, S. E. N., Diccianni, M. B., Sondel, P. M., Bender, J. G., Maris, J. M., Park, J. R. & Bagatell, R., Jul 2017, In : The Lancet Oncology. 18, 7, p. 946-957 12 p.

Research output: Contribution to journalArticle

Open Access
64 Scopus citations

MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group

DuBois, S. G., Mody, R., Naranjo, A., Van Ryn, C. J., Russ, D., Oldridge, D., Kreissman, S., Baker, D. L., Parisi, M., Shulkin, B. L., Bai, H., Diskin, S. J., Batra, V., Maris, J. M., Park, J. R., Matthay, K. K. & Yanik, G., Nov 2017, In : Pediatric Blood and Cancer. 64, 11, e26545.

Research output: Contribution to journalArticle

Open Access
11 Scopus citations
2016

Assessment of primary site response in children with high-risk neuroblastoma: An international multicenter study

Bagatell, R., McHugh, K., Naranjo, A., Van Ryn, C., Kirby, C., Brock, P., Lyons, K. A., States, L. J., Rojas, Y., Miller, A., Volchenboum, S. L., Simon, T., Krug, B., Sarnacki, S., Valteau-Couanet, D., Von Schweinitz, D., Kammer, B., Granata, C., Pio, L., Park, J. R. & 1 others, Nuchtern, J., Mar 1 2016, In : Journal of Clinical Oncology. 34, 7, p. 740-746 7 p.

Research output: Contribution to journalArticle

16 Scopus citations

Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma

Galli, S., Naranjo, A., Van Ryn, C., Tilan, J. U., Trinh, E., Yang, C., Tsuei, J., Hong, S. H., Wang, H., Izycka-Swieszewska, E., Lee, Y. C., Rodriguez, O. C., Albanese, C. & Kitlinska, J., Nov 1 2016, In : American Journal of Pathology. 186, 11, p. 3040-3053 14 p.

Research output: Contribution to journalArticle

Open Access
5 Scopus citations

Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children’s Oncology Group

Temple, W., Mendelsohn, L., Kim, G. E., Nekritz, E., Gustafson, W. C., Lin, L., Giacomini, K., Naranjo, A., Van Ryn, C., Yanik, G. A., Kreissman, S. G., Hogarty, M., Matthay, K. K. & DuBois, S. G., Mar 1 2016, In : European Journal of Nuclear Medicine and Molecular Imaging. 43, 3, p. 474-481 8 p.

Research output: Contribution to journalArticle

Open Access
8 Scopus citations